{"id":"NCT00086138","sponsor":"Johns Hopkins University","briefTitle":"Depression in Alzheimer's Disease-2","officialTitle":"Depression in Alzheimer's Disease (DIADS-2)","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2004-07","primaryCompletion":"2008-07","completion":"2009-07","firstPosted":"2004-06-28","resultsPosted":"2017-04-11","lastUpdate":"2017-04-11"},"enrollment":131,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Alzheimer's Disease","Depression"],"interventions":[{"type":"DRUG","name":"Sertraline (Zoloft)","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to learn whether treating individuals with Alzheimer's disease and depression with the anti-depressant medication sertraline (Zoloft) is helpful to people with Alzheimer's disease and to their families and caregivers.","primaryOutcome":{"measure":"Modfied Alzheimer's Disease Cooperative Study- Clinical Global Impression of Change (mADCS-CGIC)","timeFrame":"Measured at Week 12","effectByArm":[{"arm":"Sertraline","deltaMin":1,"sd":null},{"arm":"Placebo","deltaMin":0,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.98"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":5,"countries":["United States"]},"refs":{"pmids":["20087081","20672243","17068314"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":67},"commonTop":["Dizziness","Dry mouth","Diarrhea"]}}